Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Research Report 2024(Status and Outlook)
Report Overview:
Teduglutide(brand namesGattexin the US andRevestivein Europe) is a 33-membered polypeptideandglucagon-like peptide-2(GLP-2) analog that is used for the treatment ofshort bowel syndrome.
The Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size was estimated at USD 872.83 million in 2023 and is projected to reach USD 2126.56 million by 2029, exhibiting a CAGR of 16.00% during the forecast period.
This report provides a deep insight into the global Glucagon-like Peptide-2 (GLP-2) Agonist market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Glucagon-like Peptide-2 (GLP-2) Agonist Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Glucagon-like Peptide-2 (GLP-2) Agonist market in any manner.
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda Pharmaceuticals
Market Segmentation (by Type)
Gattex
Revestive
Market Segmentation (by Application)
Hospital
Pharmacy
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Glucagon-like Peptide-2 (GLP-2) Agonist Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Teduglutide(brand namesGattexin the US andRevestivein Europe) is a 33-membered polypeptideandglucagon-like peptide-2(GLP-2) analog that is used for the treatment ofshort bowel syndrome.
The Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size was estimated at USD 872.83 million in 2023 and is projected to reach USD 2126.56 million by 2029, exhibiting a CAGR of 16.00% during the forecast period.
This report provides a deep insight into the global Glucagon-like Peptide-2 (GLP-2) Agonist market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Glucagon-like Peptide-2 (GLP-2) Agonist Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Glucagon-like Peptide-2 (GLP-2) Agonist market in any manner.
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda Pharmaceuticals
Market Segmentation (by Type)
Gattex
Revestive
Market Segmentation (by Application)
Hospital
Pharmacy
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Glucagon-like Peptide-2 (GLP-2) Agonist Market
- Overview of the regional outlook of the Glucagon-like Peptide-2 (GLP-2) Agonist Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Glucagon-like Peptide-2 (GLP-2) Agonist Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Glucagon-like Peptide-2 (GLP-2) Agonist
1.2 Key Market Segments
1.2.1 Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Type
1.2.2 Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET COMPETITIVE LANDSCAPE
3.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Manufacturers (2019-2024)
3.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Manufacturers (2019-2024)
3.3 Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Sales Sites, Area Served, Product Type
3.6 Glucagon-like Peptide-2 (GLP-2) Agonist Market Competitive Situation and Trends
3.6.1 Glucagon-like Peptide-2 (GLP-2) Agonist Market Concentration Rate
3.6.2 Global 5 and 10 Largest Glucagon-like Peptide-2 (GLP-2) Agonist Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST INDUSTRY CHAIN ANALYSIS
4.1 Glucagon-like Peptide-2 (GLP-2) Agonist Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2019-2024)
6.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Market Share by Type (2019-2024)
6.4 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price by Type (2019-2024)
7 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Sales by Application (2019-2024)
7.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size (M USD) by Application (2019-2024)
7.4 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Growth Rate by Application (2019-2024)
8 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET SEGMENTATION BY REGION
8.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region
8.1.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region
8.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region
8.2 North America
8.2.1 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Takeda Pharmaceuticals
9.1.1 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Basic Information
9.1.2 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product Overview
9.1.3 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product Market Performance
9.1.4 Takeda Pharmaceuticals Business Overview
9.1.5 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist SWOT Analysis
9.1.6 Takeda Pharmaceuticals Recent Developments
10 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET FORECAST BY REGION
10.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast
10.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Country
10.2.3 Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Region
10.2.4 South America Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Glucagon-like Peptide-2 (GLP-2) Agonist by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Glucagon-like Peptide-2 (GLP-2) Agonist by Type (2025-2030)
11.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Glucagon-like Peptide-2 (GLP-2) Agonist by Type (2025-2030)
11.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast by Application (2025-2030)
11.2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) Forecast by Application
11.2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Glucagon-like Peptide-2 (GLP-2) Agonist
1.2 Key Market Segments
1.2.1 Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Type
1.2.2 Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET COMPETITIVE LANDSCAPE
3.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Manufacturers (2019-2024)
3.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Manufacturers (2019-2024)
3.3 Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Glucagon-like Peptide-2 (GLP-2) Agonist Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Sales Sites, Area Served, Product Type
3.6 Glucagon-like Peptide-2 (GLP-2) Agonist Market Competitive Situation and Trends
3.6.1 Glucagon-like Peptide-2 (GLP-2) Agonist Market Concentration Rate
3.6.2 Global 5 and 10 Largest Glucagon-like Peptide-2 (GLP-2) Agonist Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST INDUSTRY CHAIN ANALYSIS
4.1 Glucagon-like Peptide-2 (GLP-2) Agonist Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2019-2024)
6.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Market Share by Type (2019-2024)
6.4 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price by Type (2019-2024)
7 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Sales by Application (2019-2024)
7.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size (M USD) by Application (2019-2024)
7.4 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Growth Rate by Application (2019-2024)
8 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET SEGMENTATION BY REGION
8.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region
8.1.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region
8.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region
8.2 North America
8.2.1 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Takeda Pharmaceuticals
9.1.1 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Basic Information
9.1.2 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product Overview
9.1.3 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product Market Performance
9.1.4 Takeda Pharmaceuticals Business Overview
9.1.5 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist SWOT Analysis
9.1.6 Takeda Pharmaceuticals Recent Developments
10 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST MARKET FORECAST BY REGION
10.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast
10.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Country
10.2.3 Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Region
10.2.4 South America Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Glucagon-like Peptide-2 (GLP-2) Agonist by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Glucagon-like Peptide-2 (GLP-2) Agonist by Type (2025-2030)
11.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Glucagon-like Peptide-2 (GLP-2) Agonist by Type (2025-2030)
11.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast by Application (2025-2030)
11.2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) Forecast by Application
11.2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Comparison by Region (M USD)
Table 5. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon-like Peptide-2 (GLP-2) Agonist as of 2022)
Table 10. Global Market Glucagon-like Peptide-2 (GLP-2) Agonist Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Sales Sites and Area Served
Table 12. Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Product Type
Table 13. Global Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Glucagon-like Peptide-2 (GLP-2) Agonist
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Glucagon-like Peptide-2 (GLP-2) Agonist Market Challenges
Table 22. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type (Kilotons)
Table 23. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Type (M USD)
Table 24. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) by Type (2019-2024)
Table 25. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2019-2024)
Table 26. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size (M USD) by Type (2019-2024)
Table 27. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Share by Type (2019-2024)
Table 28. Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (USD/Ton) by Type (2019-2024)
Table 29. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) by Application
Table 30. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Application
Table 31. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2019-2024)
Table 33. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application (2019-2024) & (M USD)
Table 34. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Application (2019-2024)
Table 35. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Growth Rate by Application (2019-2024)
Table 36. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region (2019-2024)
Table 38. North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region (2019-2024) & (Kilotons)
Table 43. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Basic Information
Table 44. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product Overview
Table 45. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Takeda Pharmaceuticals Business Overview
Table 47. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist SWOT Analysis
Table 48. Takeda Pharmaceuticals Recent Developments
Table 49. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Region (2025-2030) & (Kilotons)
Table 50. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Region (2025-2030) & (M USD)
Table 51. North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Country (2025-2030) & (Kilotons)
Table 52. North America Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Country (2025-2030) & (M USD)
Table 53. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Country (2025-2030) & (Kilotons)
Table 54. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Country (2025-2030) & (M USD)
Table 55. Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. South America Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Consumption Forecast by Country (2025-2030) & (Units)
Table 60. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Type (2025-2030) & (Kilotons)
Table 62. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Type (2025-2030) & (M USD)
Table 63. Global Glucagon-like Peptide-2 (GLP-2) Agonist Price Forecast by Type (2025-2030) & (USD/Ton)
Table 64. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) Forecast by Application (2025-2030)
Table 65. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Comparison by Region (M USD)
Table 5. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon-like Peptide-2 (GLP-2) Agonist as of 2022)
Table 10. Global Market Glucagon-like Peptide-2 (GLP-2) Agonist Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Sales Sites and Area Served
Table 12. Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Product Type
Table 13. Global Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Glucagon-like Peptide-2 (GLP-2) Agonist
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Glucagon-like Peptide-2 (GLP-2) Agonist Market Challenges
Table 22. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type (Kilotons)
Table 23. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Type (M USD)
Table 24. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) by Type (2019-2024)
Table 25. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Type (2019-2024)
Table 26. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size (M USD) by Type (2019-2024)
Table 27. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Share by Type (2019-2024)
Table 28. Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (USD/Ton) by Type (2019-2024)
Table 29. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) by Application
Table 30. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Application
Table 31. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2019-2024)
Table 33. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application (2019-2024) & (M USD)
Table 34. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Application (2019-2024)
Table 35. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Growth Rate by Application (2019-2024)
Table 36. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region (2019-2024)
Table 38. North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Region (2019-2024) & (Kilotons)
Table 43. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Basic Information
Table 44. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product Overview
Table 45. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Takeda Pharmaceuticals Business Overview
Table 47. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist SWOT Analysis
Table 48. Takeda Pharmaceuticals Recent Developments
Table 49. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Region (2025-2030) & (Kilotons)
Table 50. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Region (2025-2030) & (M USD)
Table 51. North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Country (2025-2030) & (Kilotons)
Table 52. North America Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Country (2025-2030) & (M USD)
Table 53. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Country (2025-2030) & (Kilotons)
Table 54. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Country (2025-2030) & (M USD)
Table 55. Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. South America Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Consumption Forecast by Country (2025-2030) & (Units)
Table 60. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Type (2025-2030) & (Kilotons)
Table 62. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Type (2025-2030) & (M USD)
Table 63. Global Glucagon-like Peptide-2 (GLP-2) Agonist Price Forecast by Type (2025-2030) & (USD/Ton)
Table 64. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) Forecast by Application (2025-2030)
Table 65. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Glucagon-like Peptide-2 (GLP-2) Agonist
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size (M USD), 2019-2030
Figure 5. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size (M USD) (2019-2030)
Figure 6. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Country (M USD)
Figure 11. Glucagon-like Peptide-2 (GLP-2) Agonist Sales Share by Manufacturers in 2023
Figure 12. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share by Manufacturers in 2023
Figure 13. Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Glucagon-like Peptide-2 (GLP-2) Agonist Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Glucagon-like Peptide-2 (GLP-2) Agonist Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Type
Figure 18. Sales Market Share of Glucagon-like Peptide-2 (GLP-2) Agonist by Type (2019-2024)
Figure 19. Sales Market Share of Glucagon-like Peptide-2 (GLP-2) Agonist by Type in 2023
Figure 20. Market Size Share of Glucagon-like Peptide-2 (GLP-2) Agonist by Type (2019-2024)
Figure 21. Market Size Market Share of Glucagon-like Peptide-2 (GLP-2) Agonist by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Application
Figure 24. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2019-2024)
Figure 25. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application in 2023
Figure 26. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Application (2019-2024)
Figure 27. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Application in 2023
Figure 28. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Growth Rate by Application (2019-2024)
Figure 29. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region (2019-2024)
Figure 30. North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Country in 2023
Figure 32. U.S. Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Country in 2023
Figure 37. Germany Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region in 2023
Figure 44. China Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (Kilotons)
Figure 50. South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Country in 2023
Figure 51. Brazil Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share Forecast by Type (2025-2030)
Figure 65. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Application (2025-2030)
Figure 66. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Glucagon-like Peptide-2 (GLP-2) Agonist
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size (M USD), 2019-2030
Figure 5. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size (M USD) (2019-2030)
Figure 6. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Glucagon-like Peptide-2 (GLP-2) Agonist Market Size by Country (M USD)
Figure 11. Glucagon-like Peptide-2 (GLP-2) Agonist Sales Share by Manufacturers in 2023
Figure 12. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share by Manufacturers in 2023
Figure 13. Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Glucagon-like Peptide-2 (GLP-2) Agonist Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Glucagon-like Peptide-2 (GLP-2) Agonist Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Type
Figure 18. Sales Market Share of Glucagon-like Peptide-2 (GLP-2) Agonist by Type (2019-2024)
Figure 19. Sales Market Share of Glucagon-like Peptide-2 (GLP-2) Agonist by Type in 2023
Figure 20. Market Size Share of Glucagon-like Peptide-2 (GLP-2) Agonist by Type (2019-2024)
Figure 21. Market Size Market Share of Glucagon-like Peptide-2 (GLP-2) Agonist by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Application
Figure 24. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2019-2024)
Figure 25. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application in 2023
Figure 26. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Application (2019-2024)
Figure 27. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share by Application in 2023
Figure 28. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Growth Rate by Application (2019-2024)
Figure 29. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region (2019-2024)
Figure 30. North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Country in 2023
Figure 32. U.S. Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Glucagon-like Peptide-2 (GLP-2) Agonist Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Country in 2023
Figure 37. Germany Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region in 2023
Figure 44. China Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (Kilotons)
Figure 50. South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Country in 2023
Figure 51. Brazil Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share Forecast by Type (2025-2030)
Figure 65. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Application (2025-2030)
Figure 66. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share Forecast by Application (2025-2030)
